Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden · Delayed Price · Currency is SEK 13.90
+1.00 (7.75%)
At close: Mar 27, 2026
STO:ANNX Market Cap
STO:ANNX has a market cap or net worth of 98.12 million as of March 27, 2026. Its market cap has decreased by -38.63% in one year.
Market Cap
98.12M
Enterprise Value
70.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
13.90
Market Cap Chart
Since April 19, 2017, STO:ANNX's market cap has increased from 50.21M to 98.12M, an increase of 95.42%. That is a compound annual growth rate of 7.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 98.12M | -29.80% |
| Dec 30, 2025 | 139.77M | -39.44% |
| Dec 30, 2024 | 230.78M | 161.10% |
| Dec 29, 2023 | 88.39M | -42.68% |
| Dec 30, 2022 | 154.19M | 12.35% |
| Dec 30, 2021 | 137.24M | 9.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 133.63M |
| IRLAB Therapeutics AB | 128.26M |
| Xbrane Biopharma AB | 124.15M |
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Biovica International AB | 105.09M |
| Scandinavian ChemoTech AB | 96.73M |
| Alzinova AB | 91.12M |